BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 38512035)

  • 1. MicroRNA-451a prevents cutaneous squamous cell carcinoma progression via the 3-phosphoinositide-dependent protein kinase-1-mediated PI3K/AKT signaling pathway.
    Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
    Exp Ther Med; 2021 Feb; 21(2):116. PubMed ID: 33335579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
    Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
    J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
    Lu D; Sun L; Li Z; Mu Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
    Mei XL; Zhong S
    Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of kynureninase restrains cutaneous squamous cell carcinoma proliferation and represses the PI3K/AKT pathway.
    Ci C; Wu C; Lyu D; Chang X; He C; Liu W; Chen L; Ding W
    Clin Exp Dermatol; 2020 Mar; 45(2):194-201. PubMed ID: 31419330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of long noncoding RNA MALAT1 promotes the occurrence and progression of cutaneous squamous cell carcinoma].
    Li SS; Zhou L; Gao L; Wang YH; Ding ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):421-427. PubMed ID: 29735442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Yes-associated protein (YAP) promotes invasion and migration of cutaneous squamous cell carcinoma cells by activating the PI3K/AKT pathway].
    Li Z; Yang F; Jin X; Wang X; Chen T; Quan C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):244-251. PubMed ID: 38512035
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.